RJ Schilder, MF Brady, D Spriggs, T Shea - Gynecologic Oncology, 2003 - Elsevier Patients and Method. Patients had histologically documented epithelial ovarian
cancer and optimal initial cytoreductive surgery. No prior chemotherapy was
permitted. Adequate performance status, bone marrow, hepatic, and renal ... Cited by 28 - Related articles - BL Direct - All 6 versions
- ►ascopubs.org [PDF] DA Patt, Z Duan, S Fang, GN Hortobagyi, SH … - Journal of Clinical Oncology, 2007 - jco.ascopubs.org Purpose To evaluate the effect of antifungal prophylaxis on all-cause mortality
as primary outcome, invasive fungal infections (IFIs), and adverse events. Many
studies have evaluated the role of antifungal prophylaxis in cancer ... Cited by 30 - Related articles - All 4 versions
A Gadducci, S Cosio, PF Conte, AR … - Critical Reviews in Oncology and Hematology, 2005 - Elsevier Most patients with advanced epithelial ovarian cancer experience objective
responses to paclitaxel/platinum-based chemotherapy, but responses are generally
short-lived and the clinical outcome is still unsatisfactory. Therefore, ... Cited by 26 - Related articles - All 14 versions
ML Donato, A Aleman, RE Champlin, RM … - Bone marrow transplantation, 2004 - nature.com The purpose of this study was to identify characteristics significant to
survival and progression-free survival in patients with advanced ovarian cancer
receiving high-dose chemotherapy. In all, 96 patients received autologous ... Cited by 20 - Related articles - All 4 versions
- ►ascopubs.org V Mobus, H Wandt, N Frickhofen, C Bengala, … - Journal of Clinical Oncology, 2007 - jco.ascopubs.org Patients and Methods One hundred forty-nine patients with untreated ovarian
cancer were randomly assigned after debulking surgery to receive standard
combination chemotherapy or sequential high-dose (HD) treatment with two ... Cited by 19 - Related articles - All 4 versions
PJ Stiff, EJ Shpall, PY Liu, SP Wilczynski, … - Gynecologic Oncology, 2004 - Elsevier Results. Of 67 randomized, the 32 and 26 eligible in the CMC and CTC arms were
matched including age (median 49), maximum tumor diameter, and disease status at
transplant. Low-risk disease (maximum diameter disease ≤ 0.5 cm and ... Cited by 15 - Related articles - All 3 versions
- ►ascopubs.org [PDF] PG Rose, S Ali, E Watkins, JT Thigpen, G … - Journal of Clinical Oncology, 2007 - jco.ascopubs.org Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz, Karen L. Hagerty,
D. Craig Allred, Richard J. Cote, Mitchell Dowsett, Patrick L. Fitzgibbons,
Wedad M. Hanna, Amy Langer, Lisa M. McShane, Soonmyung Paik, Mark D. ... Cited by 13 - Related articles - All 6 versions
E Pujade-Lauraine, H Cure, C Battista, JP … - International Journal of Gynecological Cancer, 2001 - journals.lww.com Skipper summarized the results of extensive experimental studies of chemotherapy
treatment of murine tumors with the following conclusions: 1) dose intensity is
the most important factor with respect to cure in drug sensitive tumors and ... Cited by 11 - Related articles - BL Direct - All 4 versions
PP Peethambaram, HJ Long - Current Oncology Reports, 2002 - Springer Introduction Whereas primary therapy for newly diagnosed ovarian car- cinoma is
relatively standard, consisting of aggressive sur- gical cytoreduction followed
by systemic chemotherapy with paclitaxel and a platin drug, secondary ... Cited by 10 - Related articles - BL Direct - All 3 versions
P Nieboer, EGE de Vries, NH Mulder, WTA van … - Cancer treatment reviews, 2005 - Elsevier Drug resistance is a major problem in the treatment of solid tumours. Based on a
steep dose–response relationship for especially alkylating agents on tumour
cell survival, high-dose chemotherapy was considered of interest for the ... Cited by 10 - Related articles - All 6 versions
